Researchers from the Nuffield Department of Women's & Reproductive Health (NDWRH) and the MD Anderson Cancer Center shed light into the egg cell maturation in lizard ovaries by providing a detailed characterisation of the individual stages a reptile egg cell must pass through before it ovulates.
The University of Oxford has received a \u00a31.5 million gift from Bukhman Philanthropies to support new research aiming to tackle one of the most pressing challenges of our time \u2013 young people\u2019s mental health.
In Uganda\u2019s fishing communities, Dr Joseph Matovu is leading a peer-led HIV self-testing project to overcome stigma and healthcare access barriers. With support from the Africa Oxford Initiative (AfOx), the PEST4MEN model empowers local leaders to distribute self-test kits, improving uptake, linkage to care, and community ownership of HIV prevention.
Philanthropic funding from the Friedreich's Ataxia Alliance Innovation Fund awarded to five Oxford researchers to support development of novel therapeutics.
Public support for sharing health data for artificial intelligence (AI) research depends on clear public benefit, strong safeguards, and meaningful consent, according to a new Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) study based on in-depth focus groups with members of the UK public.
For decades, heart disease prevention has been one of the biggest public health success stories. Thanks to research and better awareness about risks like high blood pressure, smoking, and cholesterol, rates of heart attacks and strokes have fallen dramatically since the 1960s. But in recent years, this progress has slowed, and in some countries, even reversed.
Statins do not cause the majority of the conditions that have been listed in their package leaflets, including memory loss, depression, sleep disturbance, and erectile and sexual dysfunction, according to the most comprehensive review of possible side effects. The study was led by researchers at the Nuffield Department of Population Health and published in The Lancet.
People from minoritised groups in the UK experience a complex and interconnected set of factors that increase their risk of harm when using NHS services, according to a new qualitative study by researchers at the Nuffield Department of Population Health and the London School of Hygiene & Tropical Medicine. The study is published in BMJ Open Quality.
GSK, in partnership with the Universities of Oxford, Cambridge and Southampton, has launched Transformative Technologies in Pharmaceutical Sciences (TTPS). This cross-sector doctoral training programme will equip a new generation of researchers to translate basic scientific research and biological understanding into novel technologies, vaccines, therapies and drugs that will accelerate patient benefit. The new programme is a part of the Industrial Landscape Award programme announced by BBSRC.
Can the immune system be trained to control HIV without continuous medication? A new Oxford-led clinical trial is exploring whether immune-based strategies could support longer-term viral control after stopping antiretroviral therapy.
Obstructive sleep apnoea is one of the most common conditions occurring in sleep medicine, traditionally understood as a mechanical problem: during sleep, the upper airway is obstructed, interrupting breathing and oxygen supply. Treatments have largely focused on this anatomy, particularly through continuous positive airway pressure (CPAP) therapy.
A new state-of-the-art high-intensity focused ultrasound (HIFU) machine has been installed at the Churchill Hospital, giving Oxford University Hospitals (OUH) cancer patients access to the latest in this innovative technology.
Berlin and Oxford collaborative researchers funded by Einstein Foundation propose a new circuit theory linking a little-known cortical layer to attention and brain disorders.
The University of Oxford is pleased to announce that, as of Monday 2 February, the National Perinatal Epidemiology Unit (NPEU) has officially joined the Nuffield Department of Women\u2019s & Reproductive Health (NDWRH). \r\n\r\nThis marks a significant milestone in a partnership first announced in 2025 and represents a major strategic step in strengthening Oxford\u2019s leadership in women\u2019s, maternal and reproductive health research and education.
A new University of Oxford spinout, Oxailis Ltd, has launched an AI-based ultrasound technology that enables healthcare professionals to measure perfusion (how effectively oxygen-rich blood is delivered to tissue), using existing standard ultrasound hardware and without the need for contrast agents.
A research study by Oxford neurosurgeons and engineers is trialling whether deep brain stimulation (DBS) \u2013 delivering an electrical pulse into affected areas of the brain \u2013 can help to relieve central post-stroke pain (CPSP).
Hormone replacement therapy (HRT) is one of the most effective treatments for menopausal symptoms, yet a major new international study led by researchers from the Nuffield Department of Primary Care Health Sciences suggests that access to it is far from equal.
In an editorial piece published in The BMJ, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) Professors David Keene and Matthew Costa commend a new clinical trial that advances the understanding of ankle fracture treatment.
A new clinical study has launched to investigate whether insulin levels influence how women with the most common type of breast cancer respond to treatment.
The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration.
![\"Egg](\"https://www.medsci.ox.ac.uk/news/new-study-reveals-how-a-small-lizard-species-is-able-to-produce-eggs-for-its-entire-life/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n